SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

URSO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.437
AS - Asia 2.299
EU - Europa 1.025
SA - Sud America 483
AF - Africa 54
OC - Oceania 9
Totale 6.307
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.306
SG - Singapore 1.140
CN - Cina 422
BR - Brasile 410
IT - Italia 370
HK - Hong Kong 291
DE - Germania 179
VN - Vietnam 164
GB - Regno Unito 94
RU - Federazione Russa 64
CA - Canada 62
FI - Finlandia 61
ID - Indonesia 59
MX - Messico 59
NL - Olanda 48
IN - India 44
AT - Austria 34
PL - Polonia 32
JP - Giappone 30
AR - Argentina 28
SE - Svezia 26
BD - Bangladesh 22
FR - Francia 21
ES - Italia 20
LT - Lituania 20
ZA - Sudafrica 18
IR - Iran 17
IQ - Iraq 16
TR - Turchia 15
EC - Ecuador 14
KR - Corea 14
UA - Ucraina 13
BE - Belgio 11
MA - Marocco 10
TH - Thailandia 9
CO - Colombia 8
CZ - Repubblica Ceca 8
PY - Paraguay 8
IL - Israele 7
EG - Egitto 6
GR - Grecia 6
MY - Malesia 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
KE - Kenya 4
QA - Qatar 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AO - Angola 3
CL - Cile 3
DZ - Algeria 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
ET - Etiopia 2
HU - Ungheria 2
IS - Islanda 2
KG - Kirghizistan 2
PE - Perù 2
PT - Portogallo 2
SN - Senegal 2
TV - Tuvalu 2
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PW - Palau 1
RS - Serbia 1
SV - El Salvador 1
Totale 6.307
Salva come PNG Salva come JPEG
Città #
Singapore 642
Ashburn 415
Dallas 323
Hong Kong 291
Santa Clara 234
Beijing 197
Los Angeles 117
New York 117
Munich 68
Chicago 64
Chandler 60
Ho Chi Minh City 57
Hefei 51
Jakarta 49
Milan 41
Hanoi 38
São Paulo 37
Mexico City 36
Shanghai 36
Ferrara 33
Bologna 32
Buffalo 32
Atlanta 29
Brooklyn 29
Warsaw 28
Houston 27
London 27
Frankfurt am Main 26
Lappeenranta 25
Helsinki 23
Tokyo 23
Nuremberg 22
Denver 21
Phoenix 21
Fairfield 19
Montreal 19
Stockholm 19
Orem 18
Rome 18
Falkenstein 16
Brasília 15
Poplar 15
Salt Lake City 15
Toronto 15
Rio de Janeiro 14
Vienna 14
The Dalles 13
Turku 13
Boston 12
Dong Ket 12
Moscow 12
Johannesburg 11
Ottawa 11
Boardman 10
Chennai 10
Council Bluffs 10
Elk Grove Village 10
Manchester 10
Seattle 10
Amsterdam 9
Brussels 9
Porto Alegre 9
Assago 8
Belo Horizonte 8
Buriram 8
City of London 8
Mumbai 8
Parma 8
Wilmington 8
Ankara 7
Haiphong 7
Kansas City 7
San Francisco 7
Cambridge 6
Campinas 6
Ferrara di Monte Baldo 6
Princeton 6
Quito 6
Secaucus 6
Tampa 6
Thái Nguyên 6
Asunción 5
Athens 5
Berlin 5
Bremen 5
Brno 5
Cairo 5
Dulles 5
Düsseldorf 5
Istanbul 5
Manaus 5
Poggio Renatico 5
Querétaro 5
San Diego 5
Sydney 5
Tashkent 5
Woodbridge 5
Biên Hòa 4
Da Nang 4
Doha 4
Totale 3.863
Salva come PNG Salva come JPEG
Nome #
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 177
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 163
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma 157
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 152
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 131
18F-FDG PET/CT radiomic analysis and artificial intelligence to predict pathological complete response after neoadjuvant chemotherapy in breast cancer patients 130
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 125
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 120
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 119
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 116
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 114
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 111
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 111
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 109
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 105
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 104
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 104
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 104
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 102
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 102
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 99
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 98
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 98
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 97
Italian Association of Nuclear Medicine, Molecular Imaging and Therapy (AIMN) practical guide for peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-Oxodotreotide in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 97
Is There a Role for FAPI PET in Urological Cancers? 96
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 95
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 93
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 91
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 90
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 90
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 90
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 90
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 89
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 87
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 86
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 85
Complicated Inguinal Hernia Incidentally Detected on a Radiolabelled Autologous White Blood Cell Scan 84
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 83
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 81
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 81
68Ga-Trivehexin: Current Status of αvβ6-Integrin Imaging and Perspectives 80
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 80
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 78
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 77
[99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol 71
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 71
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 71
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 68
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 68
Radiomics Results for Adrenal Mass Characterization Are Stable and Reproducible Under Different Software 62
Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study 62
Radioligand therapy in sympathetic-adrenal-medullary axis tumors: state of art and perspectives 59
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 59
Nectin-4-Targeting Radiotracers: Novel Theranostic Agents for Precision Oncology in Cancer 57
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 57
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay 55
The Role of Radiomics and Artificial Intelligence Applied to Staging PSMA PET in Assessing Prostate Cancer Aggressiveness 55
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 53
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 51
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 50
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 50
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 48
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 48
Artificial intelligence & nuclear medicine: an emerging partnership 47
Triple Tracer PET in Advanced Prostate Cancer: Chasing Phenotypic Plasticity 47
Insights into pet-based radiogenomics in oncology: an updated systematic review 46
Molecular imaging of PARP in cancer: state-of-the-art 45
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 44
Clinical applications of long axial field-of-view PET/CT scanners in oncology 44
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 43
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 40
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 40
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 39
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 39
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 39
Synthetic imaging for research and education in nuclear medicine: Who’s afraid of the black box? 37
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 34
Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON? 29
One scan, many stories: deep learning for signal separation in multi-tracer PET imaging 27
The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est) 26
Safire CT iterative reconstruction protocol to reduce patient effective dose on PET/CT examinations 24
Radioligand Therapy with Radiolabeled Somatostatin Analogues in Metastatic Bronchial Carcinoid: an Impressive Response 19
18 F-FDG PET/CT Volumetric Metabolic Parameters in the Staging of Head and Neck Squamous Cell Carcinoma 16
Radionuclide-based nanotechnologies in triple-negative breast cancer: current evidence and future perspectives 15
Molecular Imaging in Cancer Chemoresistance: What’s Brewing? 15
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy 15
Targeting Glypican-3 in Liver Cancer: Groundbreaking Preclinical and Clinical Insights 11
Totale 6.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 32 1 5 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/20252.312 74 87 190 104 235 144 87 110 369 304 357 251
2025/20263.574 609 308 687 908 979 83 0 0 0 0 0 0
Totale 6.567